The rise in colorectal cancer among younger populations is thought to be influenced by lifestyle and environmental factors.

The relationship the immune system and stromal cells in pancreatic cancer can have a significant impact on patients' survival ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Musician Noddy Holder has told how he is enjoying performing again at 78 after his life was saved by a new pioneering type of ...

During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, ...

Key eligibility criteria were patients age 18 years or older and had undergone complete macroscopic resection for ductal adenocarcinoma of the pancreas. Country of participation and resection margin ...

Merus (MRUS) announced that the FDA approved BIZENGRI(R) (zenocutuzumab-zbco), the first and only treatment indicated for ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular subtypes using ...

The following is a summary of “An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal ...

FDA approves Merus' Bizengri as the first treatment for advanced NRG1 fusion-positive cancers. U.S. peak sales are estimated ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...